Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen
Accession Number
DB10799
Description

Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup c. The vaccine contains N. meningitis serogroup c capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.

Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Toxoid
Synonyms
  • Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine

Pharmacology

Indication
Not Available
Associated Conditions
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
MenactraNeisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL)Injection, solutionIntramuscularSanofi Pasteur Inc.2005-01-14Not applicableUS flag
MenactraNeisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL)Injection, solutionIntramuscularRemedy Repack2015-01-032016-03-29US flag
MenactraNeisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL) + Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL) + Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL) + Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL)SolutionIntramuscularSanofi Pasteur Limited2006-10-20Not applicableCanada flag

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
2J57K2523T
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910905
RxNav
797631
FDA label
Download (281 KB)

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Active Not RecruitingPreventionMeningitis / Meningococcal Infections / Meningococcal Meningitis1
4Active Not RecruitingPreventionMeningococcal Disease, Invasive1
4CompletedPreventionAcellular Pertussis / Diphtheria / Healthy Volunteers / Tetanus1
4CompletedPreventionDiphtheria / Haemophilus Influenzae Serotype b (Hib) / Meningitis / Meningococcal Infections / Pertussis / Tetanus1
4CompletedPreventionFlu caused by Influenza1
4CompletedPreventionMeningitis1
4Not Yet RecruitingPreventionPreventive Immunization; Meningitis1
3Active Not RecruitingPreventionMeningococcal Meningitis1
3CompletedPreventionCervical Neoplasia / Human Papillomavirus Type-16/-18 Infection / Papillomavirus Infections / Papillomavirus Vaccines1
3CompletedPreventionDiphtheria / Meningitis / Neoplasms, Glandular and Epithelial / Tetanus / Whooping Cough1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntramuscular
SolutionIntramuscular
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on December 01, 2015 13:04 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates